Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.
about
HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinomaA cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinomaNew progress of non-surgical treatments for hepatocellular carcinoma.Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinomaChronic ethanol diet increases regulatory T-cell activity and inhibits hepatitis C virus core-specific cellular immune responses in mice.Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas.Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies.Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma.MiR-200a inhibits cell proliferation and EMT by down-regulating the ASPH expression levels and affecting ERK and PI3K/Akt pathways in human hepatoma cells.Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway.Dendritic cells loaded with the lysate of tumor cells infected with Newcastle Disease Virus trigger potent anti-tumor immunity by promoting the secretion of IFN-γ and IL-2 from T cells
P2860
Q33779140-0390AC30-85D4-467C-9D66-2F0A48750615Q34250364-26306FAE-572D-4A4A-B033-881A531F1031Q34647076-EC7D490B-FD33-4BED-9A2D-76EE7D524FA6Q35091441-D496B36C-2A6F-4FEB-A772-FA2111D63EBBQ37445510-F4016CC6-8A62-44E7-8040-930F33277AD1Q37485171-9F439709-0EB2-4F19-AF11-F70EC3982FCAQ38177324-B46B9F9E-5C5C-4DAC-BEE3-735E8C8CC9D5Q42366399-C434B62E-B284-48CB-818A-70CD5A19B096Q54111731-422671C7-8BAD-4561-9D37-BE7866CF7552Q55378664-D8E6E6EB-384C-4D12-AE09-101CBF9D2E90Q57178786-5DB69202-632D-4E5F-B2ED-89B39FC79CFD
P2860
Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tumor progression-related tran ...... y of hepatocellular carcinoma.
@ast
Tumor progression-related tran ...... y of hepatocellular carcinoma.
@en
type
label
Tumor progression-related tran ...... y of hepatocellular carcinoma.
@ast
Tumor progression-related tran ...... y of hepatocellular carcinoma.
@en
prefLabel
Tumor progression-related tran ...... y of hepatocellular carcinoma.
@ast
Tumor progression-related tran ...... y of hepatocellular carcinoma.
@en
P2093
P2860
P1476
Tumor progression-related tran ...... y of hepatocellular carcinoma.
@en
P2093
Howard Safran
Jack Wands
Kevin P Charpentier
Masafumi Shimoda
Rolf I Carlson
Yoshito Tomimaru
P2860
P304
P356
10.1016/J.JHEP.2011.12.016
P577
2012-01-13T00:00:00Z